To evaluate platelet function in iron deficiency anemia, using impedance (in whole blood) and optic (in platelet-rich plasma methods, platelet aggregation analyses were performed in 42 children with iron deficiency anemia at the time of diagnosis and after iron therapy. Collagen-induced platelet aggregation was decreased in patients before therapy compared to after therapy and control levels as indicated by the two methods while adenosine diphosphate (ADP)-induced platelet aggregation was decreased only by the whole blood method. Platelet aggregation with epinephrine, performed only by the optic method, was not altered in patients with iron deficiency anemia. Platelet counts were found to be increased in patients with iron deficiency anemia, and decreased with therapy. These results indicate that some platelet functions are decreased in patients with iron deficiency anemia. These decreased functions may be compensated by increased platelet numbers.
Summary: To evaluate platelet function in iron deficiency anemia, using impedance (in whole blood) and optic (in platelet-rich plasma methods, platelet aggregation analyses were performed in 42 children with iron deficiency anemia at the time of diagnosis and after iron therapy. Collagen-induced platelet aggregation was decreased in patients before therapy compared to after therapy and control levels as indicated by the two methods while adenosine diphosphate (ADP)-induced platelet aggregation was decreased only by the whole blood method. Platelet aggregation with epinephrine, performed only by the optic method, was not altered in patients with iron deficiency anemia. Platelet counts were found to be increased in patients with iron deficiency anemia, and decreased with therapy. These results indicate that some platelet functions are decreased in patients with iron deficiency anemia. These decreased functions may be compensated by increased platelet numbers. Key Words: Iron deficiency&mdash;Platelet&mdash;Children.
Iron deficiency (ID) is the most common type of malnutrition in the world, and is also the main cause of anemia in children (1, 2) . In addition to hemoglobin, iron is also found in some proteins such as myoglobin and some enzymes (cytochrome, catalase, peroxidase, etc.). It has been revealed that some biological functions requiring this enzyme are affected in iron deficiency anemia (IDA) (3, 4) . Platelets contain several enzymes that have important functions in hemostasis. Some of these enzymes contain iron. Therefore, it can be expected that some platelet functions may be affected in IDA (5) (6) (7) . In this study, we examined platelet functions in children with IDA using the impedance and optic methods.
MATERIALS AND METHODS
Forty-two patients (24 male, 18 female) with IDA and 31 (19 male, 12 female) healthy children were enrolled in this study. The mean ages of the patients and control groups were 22.1 ± 4.9 and 17.2 ± 3.1 months, respectively. None of the patients and their relatives had a history of heart, liver, or renal disorders, or easy bruising, bleeding tendency, or administration of any antiaggregant drugs. The diagnosis of IDA was established with decreased complete blood count values (MCV, RBC, MCH, e.g.), serum iron, ferritin level, and iron-binding capacity. Patients with hemoglobin (Hb) levels <5 g/dL were excluded from this study because of the probability of other malnutrition states.
Aggregation studies were performed using the impedance (in the whole blood = WB) and optic (in plateletrich plasma = PRP) methods. The patients were divided into two groups according to the methods (WB group included 22 patients, and the PRP group 20 patients). Bleeding time was measured in patients and controls. A sensitive aggregometer (Linear Instruments Corp., Model 707 Recardes, Reno, NV, USA) was used for aggregation studies. The studies were performed as previously described (8) . The final concentrations of aggregant agents of the WB method were 5 pLmol for collagen, 5 jimol for adenosine diphosphate (ADP), and 1 mg/mL for ristocetin. In the PRP method, the concentrations of collagen, ADP, ristocetin, and epinephrine were 5, 5, and 10 pLmol/L and 1 mg/mL, respectively. The following values were calculated for the evaluation of aggregation: (a) maximum aggregation percent (MAP), (b) slope, and (c) lag time (delay time). Statistical analysis was performed using paired and unpaired t and chi-squared tests.
RESULTS
The hematologic parameters and bleeding time results of the study and control groups are shown in Table 1 . Baseline hematologic values were similar in both study groups (WB & PRP). Iron therapy had a similar effect on the improvement of the hematologic values in both groups. Bleeding times were found to be prolonged before treatment compared to after therapy in both groups. (p < .01), while the levels of before and after therapy were not different from those of the control group. The results of platelet aggregation (PA) for the two methods are presented in the Table 2 . Platelet aggregation was generally decreased in patients with IDA using the impedance and optic methods. This decrease improved after iron therapy. Adenosine diphosphate-induced MAP was decreased before treatment measured by the WB method (p < .05) and returned to normal after therapy. However, by the PRP method, ADP-induced PA was normal before therapy, whereas the values increased significantly above control levels (p < .05). Collagen-induced MAP was decreased in patients in both study groups. The low values increased with iron therapy. This improvement was significant in the PRP method (p < .05). Platelet aggregation with epinephrine was performed only by the PRP method. Pretreatment MAP levels were similar to the control levels, while this level increased significantly after therapy (p < .05).
The changes of slope and lag time values were generally similar to those of the MAP values for each method and each aggregant agent. Correlation analysis WB method. There was a significant correlation among collagen-induced slope and transferrin saturation, ferritin level, and MCV. The ristocetin-induced MAP showed a significant correlation with ferritin levels.
PRP method. ADP and ristocetin-induced slope showed a positive correlation with ferritin levels.
DISCUSSION
In addition to the decrease in Hb levels, IDA is also known to cause some cellular functional abnormalities (3, 4, 9, 10) . To evaluate the effect of IDA on platelet functions, we performed PA studies using the WB and PRP methods. By using two methods we could more reliably evaluate the effect of IDA on platelet functions. However, the different results obtained within the two study groups may be directly due to the two different methods TABLE 2. The results of platelet aggregation analysis of the patients and control groups * Mean ± standard error. . ** 1-2, p values of before-after therapy; 1-3, before therapy-control; 2-3, after therapy-control. ADP, adenosine diphosphate; MAP, maximum aggregation percent.
used. Even though it can be argued that iron therapy for 6 weeks may not be sufficient to improve IDA, we considered that this time is adequate to evaluate the effect of iron on platelet dysfunction. In our study, iron therapy increased MAP and slope and decreased log phase. However, some parameters did not significantly change. Although it is not completely known how IDA affects platelet functions, it has been suggested that this effect could be due to the deficiency of some enzymes that contain iron. In one study, desferrioxamine inhibited platelet aggregation and the binding of iron to lipooxygenase and cyclooxygenase, thus inhibiting their activity (11) . These enzymes are the main elements of the prostaglandin synthesis pathway. In addition, Yamazaki et al. (12) suggested that ferritin is an aggregant like agent, which can enhance platelet aggregation, and concluded that hipoferritinemia in IDA may be responsible for decreased platelet aggregation. Our finding, suggesting a positive correlation between serum ferritin levels and MAP induced by different agents corroborates this evidence. In addition, the effect of ferritin is interrupted by prostaglandin inhibiting agents such as acetyl salicylic acid (13) . In our study, platelet counts increased in patients with IDA; they returned to normal with iron therapy. Similar results were reported in previous studies. Some studies indicated that thrombocytopenia can also be seen in patients with IDA (6, 14, 15) . The finding that MPV was decreased in patients with IDA suggests that iron might be an important element for platelets, and its deficiency may result in decreased MPV. The correlation of MPV and platelet function is shown in MAP with epinephrine. In addition to our finding of the positive correlation between MPV and platelet function, it was reported that functions of small platelets in Wiskott Aldrich syndrome were decreased and the functions of large platelets in ITP were normal (16) .
The bleeding time in both groups before and after the therapy were not different compared to those of the control group, although it was significantly shortened with therapy (p < .05).
Abnormal PA decreased MPV and increased platelet count as can be seen in patients with IDA. It can be concluded that the possible bleeding tendency secondary to decreased platelet volume and function is being compensated by thrombocytosis. Further studies investigating other platelet functions of iron-binding sites on platelets can help increase the understanding of this topic.
